Immunogenicity, otitis media, hearing impairment, and nasopharyngeal carriage 6-months after 13-valent or ten-valent booster pneumococcal conjugate vaccines, stratified by mixed priming schedules: PREVIX_COMBO and PREVIX_BOOST randomised controlled trials

Amanda Jane Leach, Nicole Wilson, Beth Arrowsmith, Jemima Beissbarth, Edward Kim Mulholland, Mathuram Santosham, Paul John Torzillo, Peter McIntyre, Heidi Smith-Vaughan, Mark D. Chatfield, Deborah Lehmann, Michael Binks, Anne B. Chang, Jonathan Carapetis, Vicki Krause, Ross Andrews, Tom Snelling, Sue A. Skull, Paul V. Licciardi, Victor M. OguomaPeter Stanley Morris

    Research output: Contribution to journalArticlepeer-review

    Fingerprint

    Dive into the research topics of 'Immunogenicity, otitis media, hearing impairment, and nasopharyngeal carriage 6-months after 13-valent or ten-valent booster pneumococcal conjugate vaccines, stratified by mixed priming schedules: PREVIX_COMBO and PREVIX_BOOST randomised controlled trials'. Together they form a unique fingerprint.

    Medicine and Dentistry

    Immunology and Microbiology

    Pharmacology, Toxicology and Pharmaceutical Science